Pioneering the Development of Automated Technologies for Cell-Based Therapeutics and Bioprocessing

For more than two decades ThermoGenesis Holdings, Inc. has developed and commercialized novel cell processing systems and devices providing global researchers, biomanufacturing organizations and clinicians with highly efficient cell processing devices which helped them to deliver better outcomes in various applications in the cell and gene therapy field.

Clinical BioBanking
With over 20 years of providing cord blood to banks hospitals, researchers and stem clinicians with systems designed to handle stem cells with the highest level of precision, safety, and confidence.
Point-of-Care Solutions
We develop products to obtain bone marrow concentrates easily, consistently, and reliably from bone marrow aspirates at the point-of-care with minimal red blood cell contamination.
Cellular Processing
The first step in the process is often the most important. That's why we have created closed-system novel and innovative technologies aimed at advancing cell therapies to the clinic.

Recent News

Experimental Cell Therapies for COVID-19

More than a year after the onset of the global pandemic, the COVID-19 virus is still affecting the lives of people all around the world. While more is known about the illness today compared to 12 months ago, there is still no known cure. The start of the pandemic generated a flurry of clinical trials, … Continued

Current and Future Approaches to Immunotherapy

Immunotherapy is treatment that uses parts of a person’s immune system to fight diseases. This can take the form of stimulating the natural effects of a patient’s immune system so that it works harder and smarter to attack cancerous cells. In the last few decades, immunotherapy has played an important role in the treatment of … Continued

ThermoGenesis Holdings to Announce Financial Results for the Fourth Quarter Ended December 31, 2020 and Provide a Corporate Strategic Update

Conference Call to be Held on March 17, 2021 RANCHO CORDOVA, Calif., March 10, 2021 — ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, today announced that the Company will release its financial results for the fourth quarter ended December 31, 2020 … Continued

ThermoGenesis Leadership & Growth Throughout the Decades

Creating something that doesn’t exist, especially if it solves a real-world problem, will put a business on the map. However, having the ability to adapt to the needs of the industry and respond to changes in real time is what will ensure that the business is sustainable. In other words, innovation gets you in the … Continued

ThermoGenesis Holdings Begins a Year of Celebration of its 35th Anniversary in the Cell Banking and Cell Therapy Industry

Future corporate strategy targets large-scale cellular manufacturing needs for upcoming cell and gene therapies RANCHO CORDOVA, Calif., Feb. 17, 2021 — ThermoGenesis Holdings, Inc. (“ThermoGenesis” or the “Company”) (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, announced today that the Company will kick off a … Continued

Click below and be the first to hear about the latest news, breakthroughs, and products with the ThermoGenesis newsletter delivered directly to your inbox.
How may we help?